Delivery Order SPE2DB20D9354-SPE2DB25FX8A0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,753.25 by the Defense Logistics Agency on August 15, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 8, 2025, and no set-aside designation was applied to this award. This delivery order will be performed at the vendor's facility in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,238.39 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prolastin C 1,000 mg/20 mL vials. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,403.64 for Prolastin C 1,000 mg/20 ml vials. The award, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain operations, which serves as the government's primary source for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,273.77 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,019.40 by the Defense Logistics Agency (DLA) for the supply of Prolastin C 1,000 mg/20 ml vials. The contract employs firm fixed-price pricing with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation, reflecting the company's competitive positioning within federal...
- The Defense Logistics Agency awarded a delivery order valued at $36,122.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's broader contractual relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $18,149.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The award represents a discrete purchase order issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,132.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025, with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge facility, delivering...
- The Defense Logistics Agency awarded a delivery order valued at $36,229.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract is firm fixed-price with an ultimate completion date of October 16, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $18,149.94 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, carries a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX8A0Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,814.25 by the Defense Logistics Agency on September 24, 2025, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract carries no set-aside designation and is scheduled for ultimate completion by October 16, 2025, with performance taking place at the awardee's Park Ridge facility. This delivery order represents a specific pharmaceutical product issuance under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. This award is issued under DMS Pharmaceutical Group's significant single-award IDC with the Defense Logistics Agency valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Prolastin C, an alpha-1 proteinase inhibitor used in treating alpha-1 antitrypsin deficiency, falls within the specialized pharmaceutical portfolio covered by the master contract. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain, combined with its consistent performance delivering prescription drugs, biologics, and medical consumables to military health facilities, positions the company to efficiently fulfill this and similar delivery orders under the larger contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 9/24/25 |